Literature DB >> 1597241

Regional observer performance variation in the evaluation of gated cardiac blood pool studies.

S A Jackson1, R Nickerson, R H Martin, S Iles, D Barnes.   

Abstract

Receiver operating characteristic (ROC) analysis demonstrated that regional variations of sensitivity exist in the detection of wall motion abnormality in cardiac blood pool imaging studies. The observer response is significantly better in the apex than either the septum or posterolateral wall segments. The observer errors tend to be false-negative in the posterolateral wall segment and false-positive in the other two segments. Image presentation can make a significant difference to the overall sensitivity, and the monochrome cine-sequence performed best in this study.

Mesh:

Year:  1992        PMID: 1597241     DOI: 10.1007/bf00175138

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man.

Authors:  B L Zaret; H W Strauss; P J Hurley; T K Natarajan; B Pitt
Journal:  N Engl J Med       Date:  1971-05-27       Impact factor: 91.245

2.  Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography.

Authors:  R D Burow; H W Strauss; R Singleton; M Pond; T Rehn; I K Bailey; L C Griffith; E Nickoloff; B Pitt
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

3.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

Authors:  D G Pavel; M Zimmer; V N Patterson
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

4.  Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease.

Authors:  J S Borer; S L Bacharach; M V Green; K M Kent; S E Epstein; G S Johnston
Journal:  N Engl J Med       Date:  1977-04-14       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.